Oral blocking agent for effectively inhibiting excessive absorbing of food starch

Abstract

The invention provides an oral blocking agent for effectively inhibiting excessive absorbing of food starch. The oral blocking agent is prepared from the following raw materials of a sweetener, maltose powder, an acidity regulator, an anti-caking agent, white kidney bean extract, water-soluble fiber, tangerine fiber, kakorot extract, sodium bicarbonate, passion fruit essence, L-arabinose, essencepowder of lyme, a water retention agent, cactus extract, camellia japonica flower extract, roselle flower extract, radix gymnemae sylvestre extract, and chestnut skin extract. Compared with the priorart, the oral blocking agent has the beneficial effects that a buccal tablet product containing the natural enzyme blocking agent can be used for inhibiting the starch from being digested and absorbedby a human body, and the starch cannot be converted in the digestion process, so that the absorbing by the human body can be decreased; the inhibiting pancreatic lipase can be used for blocking the oil component from being decomposed into small molecules, and the small molecules are matched by the fiber, and then are carried out of the human body.

Description

technical field [0001] The invention is an oral blocking agent for effectively inhibiting excessive absorption of food starch, which belongs to the field of health food. Background technique [0002] Blockers, also known as receptor antagonists, are pharmacological terms that refer to a class of ligand substances that can bind to receptors and prevent the effects of agonists. Antagonists have affinity for the corresponding receptor, but have no potency, thereby inhibiting the action of the agonist on the receptor. Antagonists can bind to the active site of a receptor, or to an allosteric site, or even to a site that usually has no biological regulation alone to achieve an effect. Antagonists and receptors have different binding properties, so the binding time can be long or short, and the reversibility of binding is also different. [0003] Antagonists are classified into competitive antagonists and non-competitive antagonists. Most drug antagonists compete with endogenou...

AI Technical Summary

Problems solved by technology

[0004] Blocking agents in the prior...